Cargando…
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
Background: The effect of post-vaccination adverse events on immunogenicity is unknown. We aimed to explore relationship between post-vaccination adverse reactions and antibody levels during 6-month follow-up. Methods: Blood was serially drawn from healthcare workers after the second dose of BNT162b...
Autores principales: | Kanizsai, Andrea, Molnar, Tihamer, Varnai, Reka, Zavori, Laszlo, Tőkés-Füzesi, Margit, Szalai, Zoltan, Berecz, Janos, Csecsei, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950492/ https://www.ncbi.nlm.nih.gov/pubmed/35335080 http://dx.doi.org/10.3390/vaccines10030447 |
Ejemplares similares
-
Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme
por: Kanizsai, Andrea, et al.
Publicado: (2023) -
Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022) -
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
por: Molnar, Tihamer, et al.
Publicado: (2021) -
Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome
por: Zavori, Laszlo, et al.
Publicado: (2023) -
Acute Phase Protein Orosomucoid (Alpha-1-Acid Glycoprotein) Predicts Delayed Cerebral Ischemia and 3-Month Unfavorable Outcome after Aneurysmal Subarachnoid Hemorrhage
por: Zavori, Laszlo, et al.
Publicado: (2023)